Therapeutic trials in multiple sclerosis.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000592:standards; D003520:Cyclophosphamide / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D005071:Evoked Potentials; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D009682:Magnetic Resonance Spectroscopy; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000628:therapy*; D010919:Placebos; D010956:Plasmapheresis; D014057:Tomography, X-Ray Computed
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D010919:Placebos; D007978:Levamisole; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D007372:Interferons; D001379:Azathioprine